Explore the critical issues surrounding generic tacrolimus and cyclosporine for transplant patients. Learn about bioequivalence risks, cost savings, and strategies to manage drug level stability.
Generic immunosuppressants like tacrolimus and mycophenolate offer major cost savings for transplant patients without compromising outcomes-when used correctly. Learn how these combinations work, their real-world risks, and what patients need to know to stay safe.